News >

Long-Term Follow-Up Validates Noninferiority Between Radiation Regimens in Prostate Cancer

Jessica Hergert
Published: Wednesday, Mar 25, 2020

Vladimir Avkshtol, MD, of UT Southwestern Medical Center

Vladimir Avkshtol, MD

Moderate hypofractionated intensity-modulated radiation therapy (H-IMRT) did not show biochemical and/or clinical disease failure (BCDF) rate superiority compared with conventionally fractioned IMRT (C-IMRT) for men with intermediate- and high-risk prostate adenocarcinoma, according to long-term results of a single-center, randomized prospective trial (NCT00062309) published in the Journal of Clinical Oncology.1
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication